Endocrine Abstracts

Introduction: Chronic venous insufficiency (CVI) is a common condition that can lead to significant morbidity. Understanding the prevalence of metabolic disorders in patients with CVI is crucial for effective management and prevention of cardiovascular complications.

Objective: To evaluate the prevalence of metabolic alterations in patients with chronic venous insufficiency at a Latin American institution.

Methodology: This retrospective study involved reviewing medical records of 100 patients diagnosed with CVI, following the CEAP classification criteria. Patients over 65 years old with isolated or mixed dyslipidemia and alterations in plasma glucose levels were included. The FINDRISC score was utilized to estimate the risk of developing type 2 diabetes mellitus in these patients.

Results: The mean age of participants was 65.5 ± 5.3 years, with a female predominance of 71% compared to 29% male. The average duration of diagnosed chronic venous insufficiency was 11.5 ± 4.3 years. Elevated BMI was the most prevalent criterion for metabolic syndrome, followed by increased abdominal circumference and elevated low-density lipoprotein (LDL) cholesterol as risk factors. These findings indicate a high prevalence of metabolic syndrome criteria, contributing to an increased risk as indicated by the FINDRISC score.

Conclusion: Metabolic syndrome significantly increases the risk of cardiovascular disease in the studied population. Early identification and management of metabolic disorders in patients with chronic venous insufficiency are essential for reducing associated health risks.

Keywords: metabolic syndrome, diabetes, cholesterol, venous insufficiency.